@article{article, title  = {{Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data}},

 publisher = {{Elsevier BV}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/231688 }},

 year = {{2025}},

 month = {{7}},

 author = {{Jones C and Dutey-Magni P and Murphy LR and Murray ML and Brown JE and McCloskey E and Brown M and Amos CL and Gilbert DC and Jones RJ and Cross W et al}},

 doi = {{10.1016/j.annonc.2025.07.005}},

 journal = {{Annals of Oncology}},

 note = {{Accessed on 2025/11/03}}}